Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo.

Saved in:
Bibliographic Details
Title: Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo.
Authors: Hitchings MDT; Department of Biostatistics, College of Public Health & Health Professions, University of Florida, Gainesville, FL, USA., Ranzani OT; Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain.; Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil., Dorion M; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA., D'Agostini TL; Disease Control Coordination of the São Paulo State Department of Health, São Paulo, São Paulo, Brazil., de Paula RC; Disease Control Coordination of the São Paulo State Department of Health, São Paulo, São Paulo, Brazil., de Paula OFP; Disease Control Coordination of the São Paulo State Department of Health, São Paulo, São Paulo, Brazil., de Moura Villela EF; Disease Control Coordination of the São Paulo State Department of Health, São Paulo, São Paulo, Brazil., Torres MSS; Municipal Health Secretary of Manaus, Manaus, Amazonas, Brazil., de Oliveira SB; Pan American Health Organization, Brasília, Distrito Federal, Brazil.; Universidade de Brasília, Brasília, Distrito Federal, Brazil., Schulz W; Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA., Almiron M; Pan American Health Organization, Brasília, Distrito Federal, Brazil., Said R; Pan American Health Organization, Brasília, Distrito Federal, Brazil., de Oliveira RD; State University of Mato Grosso do Sul - UEMS, Dourados, Mato Grosso do Sul, Brazil., Silva PV; Universidade Federal de Mato Grosso do Sul - UFMS, Campo Grande, Mato Grosso do Sul, Brazil., de Araújo WN; Pan American Health Organization, Brasília, Distrito Federal, Brazil.; Universidade de Brasília, Brasília, Distrito Federal, Brazil.; National Institute for Science and Technology for Health Technology Assessment, Porto Alegre, Rio Grande do Sul, Brazil., Gorinchteyn JC; Health Secretariat of the State of São Paulo, São Paulo, São Paulo, Brazil., Andrews JR; Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA., Cummings DAT; Department of Biology, University of Florida, Gainesville, FL, USA.; Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA., Ko AI; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.; Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Bahia, Brazil., Croda J; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA. julio.croda@fiocruz.br.; Universidade Federal de Mato Grosso do Sul - UFMS, Campo Grande, Mato Grosso do Sul, Brazil. julio.croda@fiocruz.br.; Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, Mato Grosso do Sul, Brazil. julio.croda@fiocruz.br.
Source: Nature communications [Nat Commun] 2021 Oct 28; Vol. 12 (1), pp. 6220. Date of Electronic Publication: 2021 Oct 28.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2041-1723
DOI:10.1038/s41467-021-26459-6